The 1st Annual Translational Microbiome Conference
14th - 15th May 2015
- Organization:
- Arrowhead Publishers and Conferences
- Type:
- Conference
- Venue:
- To be announced
- Location:
- Boston, MA, United States
- Website:
- The 1st Annual Translational Microbiome Conference
- Phone number:
- 866-945-0263
- Area
- Life Sciences
- Specialty
- Microbiology
- Subject
- Microbiology
- Area
- Life Sciences
- Specialty
- Medicine
- Subject
- Gastroenterology
Speakers
J. Paul Brooks, Ph.D., Associate Professor, Department of Statistical Sciences and Operations Research, Fellow, Center for the Study of Biological Complexity, Virginia Commonwealth University
Jim Brown, Ph.D., Director Computational Biology, GlaxoSmithKline
Colleen Cutcliffe, Ph.D., Co-Founder and CEO, Whole Biome
Jennifer Fettweis, Ph.D., Assistant Professor, Center for the Study of Biological Complexity, VCU Lifes Sciences, Virginia Commonwealth University, Project Director, Multi-Omic Microbiome Study-Pregnancy Initiative
Robert Friedman, Ph.D., Vice President for Policy and University Relations, J Craig Venter Institute
Dale Gerding, MD, ViroPharma (now part of Shire Pharmaceuticals)
Audrey Hutchinson, Founder andCEO, Sweet Peach
Jackie Papkoff, Ph.D., VP Immunology Scientific Innovation, Johnson & Johnson California Innovation Center
Joseph Petrosino, Ph.D., Director, Alkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine, President and Founder, Metanome
Michael Snyder, Ph.D., Director, Stanford Center for Genomics and Personalized Medicine, (member of the Integrative Human Microbiome Project Research Consortium focused on Type 2 diabetes)
Larry Weiss, MD, Chief Medical Officer, AO Biome
Arrowhead Publishers, LLC is pleased to announce its 1st Annual Translational Microbiome Conference to be held May 14-15, 2015 in Boston.
This Conference will focus on the potential for translational interventions in microbiome research and the challenges the industry will need to address to make this space successful.
Therapeutic areas of research with potential for actionable interventions to be covered at this conference include:
♦ Women's Health
♦ Obesity and Type 2 diabetes
♦ Pulmonology and COPD
♦ Immunology and the Impact of C. diffiicle Infections
♦ Dermatology
♦ Periodontal Disease
Research into the microbiome is still in its infancy and yet has already revealed its potential role in a host of diseases, including obesity, Type 2 diabetes, inflammatory bowel diseases, preterm birth and Urinary Tract Infections (UTIs), as well as numerous connections between the oral microbiome and systemic diseases such as rheumatoid arthritis, cardiac disease and pancreatic cancer. Reflective of the microbiome’s potential as “the most exciting frontier in medicine,” according to Francis Collins, Director, NIH, are the numerous collaborative research projects underway, such as the Integrative Human Microbiome Project Research Consortium and the Human Microbiome Project, as well as any number of consortia at research institutions as Stanford, Arizona State University and others.
With an increasing awareness that many of our modern diseases are “lifestyle” related and that greater than 50% of current medications do not work for the individuals taking them, research in the microbiome presents a potential opportunity to provide significant preventative treatments, cures, therapies and supplements – with few or no adverse events – for a worldwide audience. Reflective of this trend is the fact that investment opportunities are growing in this area and many companies are rapidly moving towards potential translational work and the introduction of commercial ventures.
But there are numerous challenges and hurdles to be overcome before that value can be fully realized. Building on Arrowhead’s bespoke knowledge developed over the last six years of the very similar issues facing the personalized medicine space, this conference will focus not on pure research but rather on research squarely focused on the potential for translational interventions and the challenges the industry will need to address to make this space successful.
Posts
@Nature
ReplyDelete